Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.95 -0.24 (-1.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Return on Equity [ROE] (2020 - 2026)

Updated

Aurinia Pharmaceuticals' Return on Equity [ROE] was 53.12% in Q2 2026, up 35.43 percentage points from 17.69% a year earlier and up 1.21 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Aurinia Pharmaceuticals came in at 59.91%, up 58.39 percentage points from FY2024.

  • Return on Equity [ROE] has now increased for four consecutive years, with a five-year change of +88.98 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was 1.52% in FY2024 (+21.44 pp), -19.92% in FY2023 (+4.54 pp), -24.46% in FY2022 (+16.35 pp) and -40.81% in FY2021 (-11.74 pp).
  • Quarterly Return on Equity [ROE] has moved between -49.40% (Q3 2021) and 60.66% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for 17 straight quarters, with an average year-over-year change of +32.34 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 59.16 percentage points); the worst was Q4 2021 (a drop of 21.43 percentage points).
  • Per Business Quant data, AUPH's Return on Equity [ROE] in the three quarters before Q2 2026 was 51.91% (Q1 2026), 60.66% (Q4 2025) and 22.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Aurinia Pharmaceuticals 2.15 Bn 580.05 Mn 76.67 Mn 53.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.12%
Mar 31, 2026 51.91%
Dec 31, 2025 60.66%
Sep 30, 2025 22.22%
Jun 30, 2025 17.69%
Mar 31, 2025 10.94%
Dec 31, 2024 1.49%
Sep 30, 2024 -6.01%
Jun 30, 2024 -13.92%
Mar 31, 2024 -16.97%
Dec 31, 2023 -20.27%
Sep 30, 2023 -19.69%
Jun 30, 2023 -18.59%
Mar 31, 2023 -24.32%
Dec 31, 2022 -26.10%
Sep 30, 2022 -27.26%
Jun 30, 2022 -35.95%
Mar 31, 2022 -36.28%
Dec 31, 2021 -46.56%
Sep 30, 2021 -49.40%
API Access

Aurinia Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEY